Harfst & Associates Inc. reduced its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Get Rating) by 1.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,503 shares of the medical research company’s stock after selling 47 shares during the […]